Tirzepatide cost without insurance: Cheapest options in 2027

If you’ve been thinking about weight loss medications, tirzepatide has probably come up. It’s gotten a lot of attention for how effective it can be. In clinical trials, people taking tirzepatide for weight loss lost an average of about 21% of their starting body weight. 

Tirzepatide can be highly effective, but for many people, the cost is what gives them a lot to think about. What will tirzepatide cost without insurance? The monthly list prices for both tirzepatide medications are typically over $1,000.

But if you’ve ruled tirzepatide out because of the price, it may be worth taking another look. Prices can change, insurance coverage can shift, and 2026 brings some notable updates. 

Tirzepatide is sold under two brand names—Zepbound® and Mounjaro®—and what you’ll pay without insurance depends first on which one you’re prescribed.

In 2026, self-pay prices can start at $299 per month for Zepbound and $499 per month for Mounjaro®, substantially below their $1,000-plus list prices. First, find which brand fits your situation in the table below—then we’ll walk through Savings Cards, Medicare, and everything else you need to know.

Understanding the different ways to access tirzepatide and the medications that contain it can make the process feel a lot less overwhelming—and help you decide whether it makes sense for your health goals and your budget.

Tirzepatide cost and price changes for 2026 and 2027

Tirzepatide pricing has shifted quite a bit since 2025, with several key changes affecting how much people pay. Knowing what’s changed can make a real difference in managing your monthly prescription costs.

• July 1, 2026: Medicare launched a temporary GLP-1 Bridge program that gives eligible Medicare Part D members access to certain weight-loss medications through the end of 2027. For tirzepatide, only the KwikPen® multi-dose version of Zepbound® is included in the program. Learn more about eligibility and how the program works.
• February 23, 2026: Eli Lilly announced a multi-dose KwikPen^® device for Zepbound^®. The pen contains four weekly doses in a single device, offering an alternative to single-dose injection formats, with pricing ranging from about $299–$449 depending on dose.
• December 1, 2025: Eli Lilly and Company lowered cash-pay pricing for single-dose tirzepatide. Monthly pricing dropped to roughly $299–$449, depending on dose, down from previous pricing of about $349–$499.
• November 6, 2025:  Lilly and the US government announced a Most-Favored-Nation pricing agreement—the reason today’s self-pay prices and the Bridge program exist.

How much does tirzepatide cost per month? 

Retail list prices for tirzepatide medications are typically around $1,000 or more per month, with Zepbound^® listed at $1,060 per month and Mounjaro^® listed at $1,112 per month, but insurance coverage, manufacturer savings cards, and direct-pay pharmacy programs can lower what many people actually pay. 

Because of that, it’s usually more helpful to look at common payment scenarios instead of focusing only on the list price.

It’s also worth remembering that the medication itself is only part of the overall treatment cost. Many people also need ongoing clinician visits, prescription renewals, dose adjustments, and occasional lab work to monitor blood sugar and metabolic health. Depending on what your provider requires, these can add $150 to $300 per visit and $100 to $200 for labs, unless they’re bundled into a program or covered by insurance.

Another factor that affects pricing is dose escalation. Tirzepatide is started at the lowest dose and slowly increased over time to help your body adjust and minimize side effects. As doses increase, monthly pricing may change, too.

Zepbound price without insurance

Zepbound costs $299 to $449 a month without insurance through LillyDirect self-pay, against a list price of about $1,086. It is the brand for chronic weight management and for moderate-to-severe obstructive sleep apnea in obesity. The price depends on your dose: $299 at 2.5 mg, $399 at 5 mg, and $449 at 7.5-15 mg if you refill within 45 days.

Mounjaro® price without insurance

Mounjaro® costs $499 a month without insurance through LillyDirect self-pay, the same price at every dose. It is approved for type 2 diabetes, or for lowering heart risk if you have both type 2 diabetes and heart disease. It is not approved for weight loss, so the $499 price requires a prescription for an approved use.

Tirzepatide costs in 2026: Real-life scenarios

Instead of one fixed monthly price, tirzepatide costs are best understood by looking at how people actually access the medication. Depending on insurance status, savings eligibility, and pharmacy choice, monthly costs can vary significantly.

Payment scenario	Zepbound® monthly cost	Mounjaro® monthly cost	Who is this for
Full retail price	$1,080–$1,100 (for single-dose pen)	$1,000–$1,100	People paying full price at retail pharmacies without insurance or discounts.
With insurance	$25–$150	$25–$150	People whose commercial insurance plans cover the medication and who can use savings cards.
With Medicare Part D	$50	$0	Eligible Medicare Part D beneficiaries can access Zepbound® for weight loss through the Medicare GLP-1 Bridge Program for a $50 monthly copay. Only the Zepbound® KwikPen formulation is covered under the Medicare GLP-1 Bridge. Mounjaro® is available through traditional Medicare Part D plans when prescribed for type 2 diabetes.
With cash-pay discounts	$299–$449(vial and multi-dose KwikPen)	$499 flat, all doses (type 2 diabetes only)	People filling their prescription through LillyDirect or through a partner pharmacy. Mounjaro® is available through LillyDirect self-pay at $499 a month for every dose. It is approved for type 2 diabetes, not for weight loss.

*Estimated pricing varies based on eligibility, dose, coverage, and available discounts.

The cheapest way to get tirzepatide without insurance in 2027

The cheapest tirzepatide without insurance is Zepbound 2.5 mg at $299 a month through LillyDirect. Prices below are ranked cheapest first.

1. Zepbound® vial or KwikPen, 2.5 mg: $299 a month
2. Zepbound® vial or KwikPen, 5 mg: $399 a month
3. Zepbound® vial or KwikPen, 7.5–15 mg: $449 a month if you refill within 45 days
4. Mounjaro®, all doses: $499 a month (type 2 diabetes only)
5. With commercial insurance that covers the drug, a savings card: as low as $25 a month

Best price for tirzepatide by dose

The best price for tirzepatide without insurance depends on your dose. Zepbound is cheapest at the starting dose ($299 for 2.5 mg) and costs $399 at 5 mg. At 7.5-15 mg, it costs $449 if you refill within 45 days.

If you miss the 45-day window, Zepbound costs $499 at 7.5 mg and $699 at 10, 12.5, and 15 mg, so the lowest-cost tirzepatide at those doses can flip to Mounjaro®. Your diagnosis decides which brand you can use, so treat this as a price comparison, not a way to pick a brand. See the full price table by dose below

Where to buy tirzepatide without insurance: Cheapest pharmacies

The cheapest place to buy tirzepatide is LillyDirect, where the $299-$449 Zepbound and $499 Mounjaro® self-pay prices apply when you order with a valid prescription.

For Zepbound, the same KwikPen self-pay pricing is confirmed at Amazon Pharmacy, Kroger and Publix, and for pickup at Walmart through LillyDirect. Lilly says the KwikPen is available at other major pharmacies nationwide. Prices at a specific pharmacy can differ, so confirm the price before you go.

Buying tirzepatide online: The best sources

The cheapest way to buy tirzepatide online is to order through LillyDirect or a licensed pharmacy with a valid prescription. Tirzepatide is only sold with a prescription, so a seller that skips that step is a warning sign, however low the price. Be careful with any online offer priced well below $299 a month. The lowest manufacturer self-pay price is $299 for Zepbound 2.5 mg.

Tirzepatide on TrumpRx

TrumpRx lists Zepbound at $299 a month, which is the same as LillyDirect’s starting self-pay price. That makes TrumpRx a way to reach the same price, not a cheaper one. As with LillyDirect, the $299 figure is the 2.5 mg starting dose. See TrumpRx.

Will tirzepatide get cheaper in 2027?

Tirzepatide self-pay prices already dropped once: on December 1, 2025, single-dose Zepbound fell from about $349–$499 to about $299–$449.

Two dates matter for 2027. The Savings Card programs are scheduled to expire on December 31, 2026, and are expected to be reissued with new terms, and the Medicare GLP-1 Bridge runs through December 2027. There is no generic tirzepatide, and Lilly’s patent extends into the 2030s.

Tirzepatide price by dose (2.5 mg to 15 mg)

Zepbound self-pay runs from $299 at 2.5 mg to $449 at 7.5–15 mg with a timely refill, and Mounjaro® is $499 at every dose.

Dose	Zepbound self-pay, refilled within 45 days	Zepbound if you miss the 45-day window	Mounjaro® self-pay (type 2 diabetes)
2.5 mg	$299	$299 (no refill window)	$499
5 mg	$399	$399 (no refill window)	$499
7.5 mg	$449	$499	$499
10 mg	$449	$699	$499
12.5 mg	$449	$699	$499
15 mg	$449	$699	$499

Which tirzepatide brand should you look at?

Tirzepatide is one medication that has two FDA-approved brand names. Which one your prescriber writes for depends on what you’re being treated for.

Prices below are current as of September 2026; the Savings Card figures apply only through December 31, 2026, when the program is scheduled to expire and expected to re-issue with new terms.

Your situation	Brand	Self-pay route	Medicare
Type 2 diabetes	Mounjaro®	$499/month via LillyDirect	Part D, under the $2,100 CY2026 out-of-pocket cap—not eligible for the GLP-1 Bridge
Chronic weight management & Moderate-to-severe obstructive sleep apnea in obesity	Zepbound®	$299/month (2.5 mg) up to $449/month (7.5–15 mg, refilled within 45 days)	KwikPen only, through the GLP-1 Bridge at $50/month, live since July 1, 2026, through December 2027

If you have both a T2D diagnosis and obesity or OSA, your prescriber decides which brand fits your primary indication—the Savings Card and Medicare rules don’t let you pick whichever brand is cheaper that month.

Read more:

• Cheapest way to get Mounjaro® without insurance
• Cheapest way to get Zepbound® without insurance

A note on the $499 Mounjaro® price specifically: Both the LillyDirect self-pay price and the Savings Card’s uncovered-insurance tier require the prescription to be for Mounjaro®‘s FDA-approved use. That’s type 2 diabetes, or lowering heart risk if you have both type 2 diabetes and heart disease. Mounjaro® isn’t FDA-approved for weight loss.

Tirzepatide savings card, discount card and self-pay options

Manufacturer savings programs can significantly reduce the Zepbound® and Mounjaro® monthly cost—but with three overlapping programs now in play, keeping the names straight is what actually determines whether you land on $25, $299, or $499.

If you have seen these called a tirzepatide discount card or coupon, they are the same programs. A coupon from a coupon site is a different thing and is covered in the pharmacy comparison below.

Who qualifies

The (commercial) Savings Card for Zepbound®:

You generally must:

• Have commercial (private) insurance
• Have a prescription for an FDA-approved use—chronic weight management or obstructive sleep apnea (OSA)
• Not be enrolled in a government-funded program (Medicare, Medicaid, TRICARE, VA)
• Be 18 or older, a US or Puerto Rico resident

How to use it

If your insurance covers Zepbound, you pay as little as $25 for a 1-, 2-, or 3-month fill (capped at $100/$200/$300 monthly and $1,300 annually). If your insurance doesn’t cover it, you pay as low as $499 for a 1-month fill, with savings capped at the gap between retail price and $499. Either way, up to 13 fills per calendar year.

The (commercial) Savings Card for Mounjaro®:

Same structure, different indication requirement (type 2 diabetes) and different caps: $25 covered tier (capped at $150/$300/$450 monthly, $1,950 annually); $499 uncovered tier (capped at $647 monthly, $8,411 annually).

LillyDirect’s automatic self-pay:

No card to enroll in—the $299–$449 (Zepbound®) or $499 (Mounjaro) price applies automatically when you order with a valid prescription through LillyDirect.

If you have no insurance

The Zepbound KwikPen Self-Pay Savings Card:

This one doesn’t depend on your insurance status the way the two above do. It’s built for people paying cash, which is what makes it usable at participating retail pharmacies—not just through LillyDirect. It still requires an on-label prescription (weight management or OSA) and US/Puerto Rico residency, 18+. Confirm current terms directly with Lilly or your pharmacy before assuming it works the same way in every situation, especially if you also have government insurance.

If you have no insurance at all, the cheapest route is LillyDirect self-pay or the KwikPen Self-Pay Savings Card at a participating pharmacy: $299–$449 a month for Zepbound®, or $499 for Mounjaro® through LillyDirect. The two commercial Savings Cards above do not apply to you.

Tirzepatide cost without insurance: Pharmacy comparison

If you’re paying for tirzepatide without insurance, you might wonder whether one pharmacy offers a better price than another. For the Zepbound KwikPen with Lilly’s self-pay card, the answer is no: participating pharmacies charge the same $299–$449 a month as LillyDirect. Prices can differ for other formats and for coupons. Here is how it breaks down:

• Zepbound KwikPen (self-pay): $299–$449 a month at participating pharmacies, the same as LillyDirect, when you use the KwikPen Self-Pay Savings Card. You can fill your prescription locally without paying more. Confirmed pharmacies include Amazon Pharmacy, Kroger and Publix, and Walmart pickup is available through LillyDirect.
• Mounjaro® (self-pay): $499 a month through LillyDirect.
• GoodRx and other coupon sites: You might see Zepbound advertised for $299 a month, but that’s Lilly’s manufacturer price, not an additional GoodRx discount. GoodRx’s own coupons for other Zepbound formats, such as the single-dose pen, may cost considerably more.
• Amazon Pharmacy with insurance: Amazon Pharmacy also accepts Lilly’s separate commercial Savings Card for eligible people with insurance. It can lower the cost of the single-dose pen to $499 a month, but it’s different from the KwikPen self-pay program, and government-insurance holders don’t qualify for it.

Either way, self-pay purchases can’t be combined with insurance reimbursement or counted toward a deductible or out-of-pocket maximum.

If you’re eligible for Lilly’s self-pay pricing, comparing pharmacies may be more about convenience than finding a lower price. Check the final price and savings program requirements before filling your prescription.

Tirzepatide without insurance: Tips to lower your monthly cost

If you’re paying out of pocket, the cost of medications like Mounjaro® or Zepbound® can add up quickly. The good news is that there are several ways to reduce your expenses.

Here are some practical tips for how to save money on tirzepatide:

• Ask your doctor about a 90-day prescription. Some insurance plans and pharmacies offer lower overall costs for a three-month supply. In certain cases, a 90-day fill may cost the equivalent of two monthly copays instead of three.
• Use HSA or FSA funds to pay with pre-tax dollars. Because these accounts are funded with pre-tax income, this can effectively reduce the overall cost of treatment. Ask your plan administrator whether your plan covers self-pay prescriptions bought through LillyDirect or a pharmacy, and keep your receipts and prescription records.
• If you’re prescribed Zepbound®, protect your 45-day refill window. Missing it on the 7.5–15 mg doses bumps the price from $449 to $499 or $699.
• Look into financial assistance programs. Nonprofits like the PAN Foundation periodically offer grants for specialty medications.
  

Is there a generic tirzepatide?

No. As of September 2026, there is no FDA-approved generic tirzepatide for either brand. Lilly’s patent for this medicine extends into 2030. For 2026, your options are branded Mounjaro® or branded Zepbound at the prices above.

Because there is no generic, there is no generic price. The lowest tirzepatide prices are the brand-name self-pay prices: $299 a month for Zepbound® 2.5 mg and $499 a month for Mounjaro®. The timing depends on the patent, which extends into the 2030s, so a generic is not expected in 2027.

Read more: Generic tirzepatide: Why it doesn’t exist yet, when it might, and potential cost

Are there cheaper alternatives to tirzepatide?

If tirzepatide is outside your budget, other prescription weight-loss medications may cost less. Some newer GLP-1 medications have lower self-pay prices, while older medications, such as phentermine, can cost considerably less. These treatments work differently, and the amount of weight people lose can vary.

Here’s how several options compare.

Medication	How it’s taken	Cost per month without insurance	Average weight loss*
Zepbound® (tirzepatide)	Weekly injection	$299–$449	About 21%
⁠Wegovy® (semaglutide), including Wegovy HD	Weekly injection	$199–$399	About 15–19%, depending on dose
⁠Wegovy® pill (semaglutide)	Daily pill	$149–$299	About 14%
⁠Foundayo® (orforglipron)	Daily pill	$149–$299	About 11–12%
⁠Phentermine	Daily pill	Approximately $10–$50 with discounts	About 5–8%
⁠Qsymia® (phentermine/topiramate)	Daily pill	Approximately $66–$75 through qualifying offers	About 8–10%
⁠Contrave® (naltrexone/bupropion)	Daily pills	Manufacturer self-pay price to verify	About 5–8%
⁠Orlistat (Alli®, Xenical®)	Pill taken with meals	Varies by formulation	About 3–5%

Prices reflect available manufacturer self-pay programs or discount offers rather than standard retail prices. Eligibility requirements apply. Zepbound®’s $449 price for higher doses requires qualifying refills. Wegovy HD 7.2 mg costs $399 per month through NovoCare.

*Weight-loss figures are approximate results from different clinical trials, with different treatment durations, and aren’t direct comparisons.  

Why you need a prescription for tirzepatide

Tirzepatide is only available with a prescription from a licensed healthcare provider. That could be your primary care doctor, an obesity medicine specialist or endocrinologist, a nurse practitioner or physician assistant, or even a telehealth provider licensed in your state. Here’s why:

Tirzepatide dosing is gradually increased over time

Treatment starts at a low dose (2.5 mg once weekly) and is increased every 4 weeks or longer if needed. This helps your body adjust and reduces side effects. Your provider will work with you to find the lowest effective dose that delivers results while keeping side effects manageable.

Learn more: Tirzepatide dosage guide: How to find the right dose for you

Tirzepatide can cause side effects that need monitoring

Common side effects include nausea, vomiting, diarrhea, constipation, and stomach discomfort. These often improve over time, but your provider will monitor how you’re doing and make adjustments if needed. Ongoing check-ins help keep treatment both safe and effective.

Learn more: Tirzepatide side effects: Symptom guide and management tips

Some people shouldn’t take tirzepatide

Tirzepatide isn’t right for everyone. Your healthcare provider will review your medical history, current medications, and overall health before prescribing it.

You can’t take tirzepatide if:

• You or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
• You’ve had a serious allergic reaction to tirzepatide or any of its ingredients.
• You are pregnant, planning to become pregnant, or breastfeeding.

Your provider may recommend avoiding tirzepatide if you:

• Have a history of pancreatitis or severe digestive conditions like gastroparesis.

How to get a prescription for tirzepatide without insurance: Telehealth vs. in-person

There’s more than one way to get a prescription for tirzepatide, even paying out of pocket, and how you get it matters almost as much as the medication cost itself.

In person: A primary care provider, obesity-medicine specialist, or endocrinologist—means paying per visit: an initial visit often runs $200 or more, follow-ups around $150 each, with lab work billed separately. Specialists tend to run higher.

Telehealth programs focused on weight or metabolic health often use a flat monthly fee instead, covering the clinician evaluation, prescription management, and follow-ups in one predictable payment—usually the more predictable route if you’re paying without insurance. Medication is billed separately either way.

Instead of paying per visit or navigating specialist referrals, Noom combines clinician evaluation, prescription support, and ongoing behavior-change tools in one place. If prescribed, you’ll fill the prescription at the pharmacy of your choice, and you’ll also receive Noom’s full program, GLP-1 Companion access, and support from a dedicated Care Team.

Who is eligible for GLP-1 medication through Noom? Noom is built for people who may need extra medical support to reach their health goals. A licensed clinician reviews your health history to decide if prescription weight-loss medications—including GLP-1s—are a good fit for you.

When does insurance cover tirzepatide?

Insurance coverage for tirzepatide can vary widely depending on your diagnosis and your specific insurance plan. In general, insurers are more likely to cover Mounjaro® when it’s prescribed for type 2 diabetes and Zepbound® when it’s prescribed for obstructive sleep apnea (OSA). Weight loss is unlikely but worth checking because plans change. 

Employer-sponsored and private plans

Coverage for Zepbound® for weight loss is less consistent, and unlikely for Mounjaro® as an off-label use. Many plans still treat obesity medications as optional benefits, so some people may need to pay the full cost unless their insurance includes weight-loss drug coverage.

Most insurance plans that do cover Zepbound® or Mounjaro® also require prior authorization (PA) before approving tirzepatide. This means your healthcare provider must submit documentation showing why the medication is medically necessary and that other treatments may not have worked.

Medicare and tirzepatide in 2026: Part D vs. the GLP-1 Bridge

Whether you qualify for tirzepatide through Medicare Part D or the GLP-1 Bridge Program can be confusing. Here’s a few scenarios that can help you figure out which program you may qualify for:

Medicare + type 2 diabetes → Part D.
Mounjaro® is covered on Part D formularies for its labeled diabetes use, subject to your plan’s prior authorization rules. The 2026 out-of-pocket cap is $2,100, with a $615 deductible. People using Mounjaro® are ineligible for the GLP-1 Bridge.

Medicare + weight management or OSA → GLP-1 Bridge.
The Bridge program has been live since July 1, 2026, and runs through December 31, 2027. It covers the Zepbound® KwikPen (along with Wegovy® and Foundayo®) at a flat $50/month copay for eligible people. Zepbound® single-dose pens and vials don’t qualify—only the KwikPen.

One important distinction between Part D and Bridge coverage:

• The Bridge operates outside the standard Part D benefit entirely. That cuts both ways. The $615 Part D deductible doesn’t apply to a Bridge prescription—but the $50 monthly copay also doesn’t count toward the $2,100 Part D out-of-pocket cap.
• If you’re on the Bridge for Zepbound® and separately filling other Part D drugs, don’t expect the $50 payments to help you reach that $2,100 threshold faster.

Frequently asked questions (FAQs) about tirzepatide cost without insurance

Does the $299 Zepbound® price stay the same as my dose increases?

No. $299 is the price for the 2.5 mg starting dose only. It’s $399 at 5 mg, and up to $449 at 7.5–15 mg (the maintenance-dose range), provided you refill within 45 days of your previous order.

What happens if I don’t refill Zepbound® within 45 days?

For the 7.5, 10, 12.5, and 15 mg doses, the $449 self-pay price requires completing your next purchase within 45 days of receiving your previous order. Miss that window, and Lilly’s listed regular self-pay prices are $499 for 7.5 mg and $699 for 10, 12.5, and 15 mg.

The 2.5 mg and 5 mg tiers ($299 and $399) don’t require a 45-day refill.

 Is Mounjaro® the same as Zepbound®?

They are different FDA-approved brands of the same medication. The difference comes down to why you take it: Mounjaro® is for type 2 diabetes, Zepbound® is for weight management and OSA. Because the labels differ, so do the savings-card rules and Medicare coverage.

Does Medicare cover tirzepatide?

It depends on why you’re taking it. For type 2 diabetes, Mounjaro® is covered through Part D. For weight management or OSA, the Zepbound® KwikPen is covered through the Medicare GLP-1 Bridge at $50/month through 2027. Mounjaro® isn’t part of the Medicare GLP-1 Bridge Program.

How much is tirzepatide out of pocket?

It depends on your insurance status and which form you use, but here’s the short version: with commercial insurance and the savings card, as little as $25/month. With commercial insurance that doesn’t cover it, as low as $499/month.

Without any insurance, the self-pay program through LillyDirect brings it to $299 to $449 per month for the KwikPen or vials, depending on dose.

Without any discounts at retail, expect $1,000 to $1,100 per month. Keep in mind these are medication costs only — clinician visits, lab work, and other monitoring may add to your total out-of-pocket costs.

Do Noom costs include Zepbound®?

No, Noom fees cover consultations with your clinician, prescription and side effect management (helping coordinate refills and dosage adjustments), but medication costs are separate. You’ll fill your tirzepatide prescription independently through your chosen pharmacy or manufacturer program. Noom helps streamline the prescription process and ongoing care at a predictable monthly rate. We can also help you check if your insurance covers GLP-1 medication in minutes with Noom’s Insurance Checker. 

Does the monthly cost of tirzepatide include doctor visits?

No. The monthly price of tirzepatide medications typically covers only the medication itself, not doctor visits or lab tests. You’ll still need a healthcare provider to prescribe and monitor the treatment, which may involve periodic appointments and blood work. 

What is the best price for tirzepatide without insurance?

The lowest price is $299 a month for Zepbound® 2.5 mg through LillyDirect. It rises to $399 at 5 mg and $449 at 7.5–15 mg if you refill within 45 days. Mounjaro® is a flat $499 at every dose but is approved only for type 2 diabetes. Your diagnosis, not the price, decides which brand you can use.

Is it safe to buy tirzepatide online?

It is safe only from a licensed pharmacy that requires a valid prescription. The lowest verified price is $299 a month for Zepbound® 2.5 mg through LillyDirect.

Will tirzepatide get cheaper?

Self-pay prices fell on December 1, 2025, from about $349–$499 to about $299–$449 for single-dose Zepbound®. There is no generic yet because Lilly’s patent extends into the 2030s. Savings Cards are scheduled to expire on December 31, 2026, and are expected to re-issue with new terms.

The bottom line: The cost of tirzepatide can vary depending on the medication and coverage

Tirzepatide medications like Mounjaro® and Zepbound® can be expensive at first glance, but the price mostly comes down to three things:

1. Which brand your diagnosis points to (type 2 diabetes vs. weight loss/OSA)
2. Whether you have commercial insurance or Medicare that covers it
3. Which self-pay program you use

Manufacturer self-pay pricing starts around $299 per month for Zepbound® and $499 per month for Mounjaro®. Savings Cards can reduce costs further for eligible people. And Medicare now covers a path for each brand, though the two paths (Part D and the GLP-1 Bridge) work differently.

It’s also important to consider the full cost of care—not just the medication itself. Doctor visits, prescription management, and lab work may add to your total expenses, which is why some people prefer programs that bundle clinical support into a predictable monthly fee.

Because insurance coverage rules and manufacturer programs can change over time, staying informed about the latest options can help you plan ahead and keep treatment more affordable. If you’re exploring tirzepatide for weight management, programs like Noom can help connect you with licensed providers while offering tools and support designed to help you stay on track.

If you have Medicare, find out how Noom can help you access Zepbound® for $50/month through the Medicare GLP-1 Bridge Program. See if you’re eligible for the Noom Medicare Bridge.

Note: Mounjaro® is not FDA-approved to treat obesity or for weight loss.